The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.

Spargo, Andrew; Yost, Christopher; Squires, Patrick; Raju, Aditya; Schroader, Bridgette; Brown, Joshua D

Spargo, Andrew; Yost, Christopher; Squires, Patrick; Raju, Aditya; Schroader, Bridgette; Brown, Joshua D.

Affiliation

Spargo A; Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, and Xcenda, Palm Harbor, FL.
Yost C; Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, and Xcenda, Palm Harbor, FL.
Squires P; Department of Pharmaceutical Outcomes & Policy and Center for Drug Evaluation & Safety, University of Florida College of Pharmacy, Gainesville, FL.
Raju A; Xcenda, Palm Harbor, FL.
Schroader B; Xcenda, Palm Harbor, FL.
Brown JD; Department of Pharmaceutical Outcomes & Policy and Center for Drug Evaluation & Safety, University of Florida College of Pharmacy, Gainesville, FL.

J Manag Care Spec Pharm ; 27(5): 554-564, 2021 May.

Article de En | MEDLINE | ID: mdl-33908275

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la bouche / Leucémie myéloïde chronique BCR-ABL positive / Dépenses de santé / Couverture d'assurance / Adhésion au traitement médicamenteux Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: J Manag Care Spec Pharm Année: 2021 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google